Eubanks Richard M., President and CEO, has demonstrated a clear long-term accumulation bias in shares of Brink’s Company (BCO), with $14.8 million in total buy value outweighing $9.4 million in sales across 60 transactions. His activity in BCO shares has been concentrated in periodic acquisitions, including a significant $14.5 million purchase on February 18, 2026, alongside smaller recurring buys—often in the range of $3,800 to $11,375—dating back to at least September 2025. These smaller transactions appear systematic, possibly tied to compensation or dividend reinvestment. Sales have been less frequent but notable, including a $4.4 million disposition on the same February 2026 date, suggesting partial profit-taking or portfolio rebalancing. Recent filings from March 2026 show smaller transactions, including derivative adjustments (codes D and F) with no immediate dollar impact, alongside minor equity awards (code A). The pattern reflects a net bullish stance on BCO, with large-scale buying punctuated by occasional sell-offs, though no recent trades indicate a shift in direction. Eubanks’s activity remains exclusively tied to Brink’s, with no diversification across other securities.
AI-assisted summary